TWAPF
Price:
$16.83
Market Cap:
$129.02B
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2009-10-21
Stock Exchange
PNK
Ticker
TWAPF
According to Towa Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 6.16. This represents a change of -54.51% compared to the average of 13.54 of the last 4 quarters.
The mean historical PE Ratio of Towa Pharmaceutical Co., Ltd. over the last ten years is 14.27. The current 6.16 PE Ratio has changed 4.22% with respect to the historical average. Over the past ten years (40 quarters), TWAPF's PE Ratio was at its highest in in the March 2023 quarter at 107.46. The PE Ratio was at its lowest in in the December 2022 quarter at -37.04.
Average
14.27
Median
10.24
Minimum
7.69
Maximum
42.38
Discovering the peaks and valleys of Towa Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 398.66%
Maximum Annual PE Ratio = 42.38
Minimum Annual Increase = -79.68%
Minimum Annual PE Ratio = 7.69
Year | PE Ratio | Change |
---|---|---|
2024 | 8.61 | -79.68% |
2023 | 42.38 | 398.66% |
2022 | 8.50 | -1.34% |
2021 | 8.61 | 11.98% |
2020 | 7.69 | -33.99% |
2019 | 11.65 | -35.85% |
2018 | 18.16 | 9.68% |
2017 | 16.56 | 65.99% |
2016 | 9.98 | -4.99% |
2015 | 10.50 | -16.89% |
The current PE Ratio of Towa Pharmaceutical Co., Ltd. (TWAPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.83
5-year avg
15.16
10-year avg
14.27
Towa Pharmaceutical Co., Ltd.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Towa Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Towa Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Towa Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Towa Pharmaceutical Co., Ltd. (TWAPF)?
What is the highest PE Ratio for Towa Pharmaceutical Co., Ltd. (TWAPF)?
What is the 3-year average PE Ratio for Towa Pharmaceutical Co., Ltd. (TWAPF)?
What is the 5-year average PE Ratio for Towa Pharmaceutical Co., Ltd. (TWAPF)?
How does the current PE Ratio for Towa Pharmaceutical Co., Ltd. (TWAPF) compare to its historical average?